CANTEL MEDICAL INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cantel Medical Corp - CMD
and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Cantel Medical Corp (NYSE: CMD) to STERIS plc (NYSE: STE).
- and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Cantel Medical Corp (NYSE: CMD) to STERIS plc (NYSE: STE).
- Under the terms of the proposed transaction, shareholders of Cantel will receive only $16.93 in cash and 0.33787 of a STERIS ordinary share for each share of Cantel that they own.
- KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
- To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .